Burke Sara S - OmicsDI

Show results for

Unknown (13)
Metabolomics (3)
Genomic (1)

Repository

MetaboLights (3)
dbGaP (1)

Technology Type

Mass spectrometry (3)

Instrument Platform

Exactive (Thermo Scientific) (1)
Gas Chromatography MS - positive (1)
SYNAPT HDMS (Waters) (1)

Publication Date

2022 (1)
2016 (1)
2015 (1)

CHEBI ID

CHEBI:18186 (2)
CHEBI:24898 (2)
CHEBI:25017 (2)
CHEBI:28044 (2)
CHEBI:1148 (1)
CHEBI:134221 (1)
CHEBI:134223 (1)
CHEBI:134224 (1)
CHEBI:15356 (1)
CHEBI:15428 (1)
CHEBI:15429 (1)
CHEBI:1547 (1)
CHEBI:15978 (1)
CHEBI:16199 (1)
CHEBI:16347 (1)
CHEBI:16393 (1)
CHEBI:16449 (1)
CHEBI:16750 (1)
CHEBI:16811 (1)
CHEBI:16958 (1)
CHEBI:17268 (1)
CHEBI:17368 (1)
CHEBI:17822 (1)
CHEBI:18012 (1)
CHEBI:18183 (1)
CHEBI:18257 (1)
CHEBI:20067 (1)
CHEBI:20096 (1)
CHEBI:22653 (1)
CHEBI:22660 (1)

Metabolite Name

(1,2,3-trimethyl-2-cyclopropen-1-yl)benzene (1)
(1-methylbutyl)cyclopentane (1)
(1R,4S)-4,7,7-trimethylbicyclo[4.1.0]hept-2-ene (1)
(2E)-1,4-dimethoxybut-2-en-1-yl acetate (1)
(E)-hept-4-en-2-one (1)
(E)-hex-2-enoate (1)
(E,E)-2,4-octadien-1-ol, acetate (1)
(E,Z)-farnesol (1)
(RS)-3-methyl-4-{[(Z)-prop-1-enyl]oxy}butanal (1)
(S)-(+)-2-heptanol (1)
(Z,E)-alpha-farnesene (1)
(trans)-3,4-oxa-2,5-dimethylhexane (1)
1, 1, 5-trimethyl-1, 2-dihydronaphthalene (1)
1,1,6-trimethyltetralin (1)
1,2-dichlorobenzene (1)
1,2-dimethyl 1,2,4-benzenetricarboxylate (1)
1,2-diphenylpropane (1)
1,2-propanediol (1)
1,3-diacetoxypropane (1)
1,3-oxathiane (1)
1,4-diacetoxybutane (1)
1,4-dioxane (1)
1-(1-ethoxyethoxy)-butane (1)
1-(1-ethoxyethoxy)pentane (1)
1-(1-methylethoxy)-2-propanone (1)
1-(2-phenethyl)imidazolidine-2,4,5-trione (1)
1-bromo-4-cyclopropylbenzene (1)
1-butanol (1)
1-decene (1)
1-decyne (1)

Release Date

2021 (6)
2023 (4)
2024 (2)
2022 (1)

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

Machine Learning-Based Retention Time Prediction of Trimethylsilyl Derivatives of Metabolites

In gas chromatography-mass spectrometry-based untargeted metabolomics, metabolites are identified by comparing mass spectra and chromatographic retention time with reference databases or standard materials. In that sense, machine learning has been used to predict the retention time of metabolites la...

2022-05-26 | MTBLS2841 | MetaboLights

Molecular characterization of firefly nuptial gifts: a multi-omics approach sheds light on postcopulatory sexual selection

Postcopulatory sexual selection is recognized as a key driver of reproductive trait evolution, including the machinery required to produce endogenous nuptial gifts. Despite the importance of such gifts, the molecular composition of the non-gametic components of male ejaculates and their interactions...

2016-12-22 | MTBLS362 | MetaboLights

Automated Label-free Quantification of Metabolites from Liquid Chromatography–Mass Spectrometry Data (Plasma)

Liquid chromatography coupled to mass spectrometry (LC-MS) has become a standard technology in metabolomics. In particular, label-free quantification based on LC-MS is easily amenable to large-scale studies and thus well suited to clinical metabolomics. Large-scale studies, however, require autom...

2015-12-16 | MTBLS234 | MetaboLights

Whole Genome Association Study of Visceral Adiposity in the HABC Study

The Health Aging and Body Composition (Health ABC) Study is a NIA-sponsored cohort study of the factors that contribute to incident disability and the decline in function of healthier older persons, with a particular emphasis on changes in body composition in old age. Between 4/15/97 and 6...

phs000169 | dbGaP

International Impact of COVID-19 on the Diagnosis of Heart Disease.

Not available

S-EPMC7836433 | biostudies-literature

Simvastatin in Critically Ill Patients with Covid-19.

Not available

S-EPMC10755839 | biostudies-literature

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial.

Not available

S-EPMC11170452 | biostudies-literature

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.

Not available